Nature-Inspired Virtual Reality Boosts Emotional Well-Being In Older Adults Living With Dementia
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….
Neural anticipation of virtual infection triggers an immune response
On Jul. 28, 2025, a study published in Nature Neuroscience shows that potential contact with approaching infectious avatars,…
Long-term exposure to outdoor air pollution linked to increased risk of dementia
On Jul. 24, 2025, an analysis of studies incorporating data from almost 30 million people has highlighted the…
Northwestern scientists studied 174 brain samples. CTE and aging were difficult to distinguish
On Jul. 11, 2025, findings from Northwestern University study show the brain protein tied to CTE is not…
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approves updated label for Lilly’s Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer’s disease
On Jul. 9, 2025, Eli Lilly announced that the U.S. Food and Drug Administration (FDA) has approved a…
BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
Common gene variant doubles dementia risk for men
On May 30, 2025, researchers from Curtin Medical School reported that they have found that men who carry…
Biology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
FDA clears first blood test for Alzheimer’s detection
On May 16, 2025, the U.S. Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose…
UW Medicine offers second drug for early Alzheimer’s
On Apr. 25, 2025, University of Washington announced that the Memory & Brain Wellness Center at Harborview Medical…
Scientists Identify Key Enzyme in Alzheimer’s Disease That Links Brain Inflammation to Memory Loss
On Apr. 14, 2025, a research team at the Institute for Basic Science (IBS) in Korea announced they…
New mouse models can bridge gap in Alzheimer’s research
On Apr. 7, 2025, in a landmark study, researchers at University of Nebraska Medical Center (UNMC) announced they…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Tufts Research suggests Connection Between Concussions, Viruses, and Alzheimer’s
On Jan. 7, 2025, researchers at Tufts University and Oxford University announced they have uncovered mechanisms connecting trauma…
New Research Identifies Key Cellular Mechanism Driving Alzheimer’s Disease
On Dec. 23, 2024, researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC)…
University of Queensland ultrasound treatment for Alzheimer’s licensed to new startup
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
How fast is your brain ageing? Proteins in blood offer clues
On Dec. 9, 2024, neurologists at Fudan University in Shanghai, China have identified 13 proteins in the blood…
Biotechnology | Chemical | Diagnostics | Disease | Neurology
TGen-ASU study revealed lasting effects of common herbicide on brain health
On Dec. 4, 2024 a study led by researchers from TGen and Arizona State University showed that pre-clinical models exposed…
AARP and Leading Research Organizations Announced Risk Factors of Dementia Research Findings
On Nov. 15, 2024, the AARP, the Alzheimer’s Disease Data Initiative (AD Data Initiative), and the Institute for…
Alzheimer’s and alcohol use disorder share similar gene expression patterns
On Nov. 5, 2024, Scripps research scientists reported they have shown that Alzheimer’s and alcohol use disorder (AUD)…
Neuroscientists revealed Integrated multimodal cell atlas of Alzheimer’s disease
On Oct, 14, 2024, a team of researchers from the Allen Institute of Brain Science and the University…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Biology | Biotechnology | Diagnostics | Disease | Medicine | Neurology | Non-Profit Research | Therapeutics
landmark UT Health San Antonio study found genetic risk-factor overlap between Alzheimer’s disease, and dementias
On Sept. 17, 2024, in landmark research, scientists at The University of Texas Health Science Center at San…
first drug approved for early Alzheimer’s disease in the UK
On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
“LEQEMBI®” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Hong Kong
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
Diagnostics | Disease | Medical Device | Nanotechnology | Neurology | Non-Profit Research | Therapeutics
Imaging technique shows new details of peptide structures
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
‘LEQEMBI’ (Lecanemab) approved for treatment of Alzheimer’s disease in China
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…